Tag: Obesity
Obesity drugs weighing heavily on employee healthcare costs
93% of global businesses cover weight-management drugs in their healthcare plans
Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for...
The agreement strengthens Lupin’s diabetes portfolio and accelerates its presence in the obesity segment
Cipla launches Yurpeak for the treatment of Obesity and Type 2...
A prescription medicine to be used under medical advice, it will be available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg strengths
Lilly’s oral GLP-1 Orforglipron clears third Phase 3 trial, set for...
Participants with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost an average of 10.4 kg (10.5%) on the highest dose, with A1C reduced by an average of 1.8%
Post CDSCO approval, Lilly launches Mounjaro, a first of its kind...
The drug delivers superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials
Lilly’s GBP279 million investment set to boost UK life sciences sector
As per GlobalData, the initiative is set to accelerate early-stage ventures and spearhead advancements in obesity treatments, invigorating the UK life sciences sector
Surge in kidney disease among young adults raises alarm across India
Healthcare experts call for lifestyle changes and increased awareness as end-stage renal disease cases rise in adults aged 25-55
Health Ministry releases revised guidelines for Non-Alcoholic Fatty Liver Disease
Health Ministry's new guidelines and training manual aim to improve early detection and care for NAFLD, a growing public health concern
70% surge observed in PCOS cases in the last five years,...
Unhealthy lifestyle choices contribute to the rise in PCOS cases, linked to insulin resistance and increased health risks
GLP1R innovator drugs drive over $6.2 billion in licensing agreement deals...
Biopharmaceutical companies are now focusing on advancing these drugs to enhance efficacy and expand their therapeutic scope beyond type 2 diabetes and obesity